South Korean startup Lunit, developer of two FDA-cleared AI models for healthcare, went public this week on the country’s Kosdaq stock market. The move marks the maturity of the Seoul-based company — which was founded in 2013 and has for years been part of the NVIDIA Inception program that nurtures cutting-edge startups. Lunit’s AI software Read article >
The post Shifting Into High Gear: Lunit, Maker of FDA-Cleared AI for Cancer Analysis, Goes Public in Seoul appeared first on NVIDIA Blog.